Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 13 Nov 2024

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

in Pharmacoepidemiology

Wan Xiong
Yilin Li
Lin Hu
Gefei He
Juanjuan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458500

3,899 views
4 citations

Original Research

Published on 12 Nov 2024

Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)

in Pharmacoepidemiology

Payam Peymani
Anick Berard
Brandace Winquist
Padma Kaul
Odile Sheehy
Alekhya Lavu
Christine Leong
Jamie Falk
Joseph A. Delaney
Kaarina Kowalec

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469552

2,653 views
1 citation

Systematic Review

Published on 12 Nov 2024

Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials

in Pharmacoepidemiology

Huan Wang
Jiaqi Zheng
Qing Zhang
Zhongping Tian
Yuhang Sun
Tianyi Zhu
Yanlong Bi
Li Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410172

4,543 views
1 citation

Brief Research Report

Published on 11 Nov 2024

Dispensing of zolpidem and benzodiazepines in Brazilian private pharmacies: a retrospective cohort study from 2014 to 2021

in Pharmacoepidemiology

Fabiana Carvalho
André Comiran Tonon
Maria Paz Hidalgo
Manuela Martins Costa
Sotero Serrate Mengue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405838

3,858 views
3 citations

Original Research

Published on 07 Nov 2024

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)

in Pharmacoepidemiology

Lin Chen
Zhicheng Dai
Huangrong Song
Jiafeng Zhang
Tuo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1473756

4,609 views
3 citations

Original Research

Published on 06 Nov 2024

Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

in Pharmacoepidemiology

Yingyong Ou
Zhiwei Cui
Siyu Lou
Chengyu Zhu
Junyou Chen
Linmei Zhou
Ruizhen Zhao
Li Wang
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463657

8,402 views
8 citations

Original Research

Published on 06 Nov 2024

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study

in Pharmacoepidemiology

Muhammed Jabir
Vijayakumar Balakrishnan
Kaliannagounder Krishnamoorthy
Ashwani Kumar
Philip Raj Abraham

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1429653

1,867 views
1 citation

Original Research

Published on 05 Nov 2024

Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data

in Pharmacoepidemiology

Eduardo Gutiérrez-Abejón
M. Aránzazu Pedrosa-Naudín
Diego Fernández-Lázaro
Isabel Díaz Planelles
F. Javier Álvarez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425442

2,771 views
3 citations

Original Research

Published on 01 Nov 2024

Sex bias in prospective follow-up observational studies with drugs carried out in a southern region of Europe

in Pharmacoepidemiology

Àlex Santomà
Anna Maria Jambrina
Adela Perisé
Mercè Armelles
Lluisa Perisé
Clara Pareja
Neus Rams
Manel Rabanal

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427293

6,165 views
1 citation

Original Research

Published on 30 Oct 2024

Prevalence and influence factor of drug-related problems in inpatients with kidney disease: a prospective single central study

in Pharmacoepidemiology

Guoguang Gu
Yanping Li
Yunyun Hu
Hengyi Zhao
Xingdong Wang
Xiaomin Li
Xinran Zhang
Hong Zhu
Xiaohua Dai
Xingxing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436561

2,226 views

Original Research

Published on 30 Oct 2024

Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study

in Pharmacoepidemiology

Hayeon Kim
Jun-Ho Seo
Jin Hyun Nam
Yejee Lim
Kyung Hee Choi
Kyungim Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443175

4,346 views
2 citations

Original Research

Published on 28 Oct 2024

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis

in Pharmacoepidemiology

Yuchen Guo
Victoria Y. Strauss
Martí Català
Annika M. Jödicke
Sara Khalid
Daniel Prieto-Alhambra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395707

2,586 views
3 citations

Original Research

Published on 22 Oct 2024

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration

in Pharmacoepidemiology

Jing Zhang
Xiaofen Wang
Yiting Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471615

8,072 views
8 citations

Original Research

Published on 22 Oct 2024

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

in Pharmacoepidemiology

Ye Xu
Bin Zhao
Liqun He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438292

5,511 views
5 citations

Systematic Review

Published on 17 Oct 2024

Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials

in Pharmacoepidemiology

Jing Lyu
Fei Fan
Ji Li
Qiong Wang
Xue Tian
Jiaxing Xu
Si Zhang
Bo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431706

3,256 views
1 citation

Original Research

Published on 15 Oct 2024

Nationwide usage of ethambutol and incidence and screening practices of optic neuropathy

in Pharmacoepidemiology

Jiyeong Kim
Hyeon Yoon Kwon
Seong Joon Ahn

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461111

2,815 views
5 citations

Original Research

Published on 14 Oct 2024

Community pharmacists’ role towards preventing abuse or misuse and dependence of codeine-containing analgesic medications in Saudi Arabia: a multicenter cross-sectional study

in Pharmacoepidemiology

Muteb Alanazi
Mukhtar Ansari
Tareq Nafea Alharby

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408024

3,516 views
3 citations

Original Research

Published on 14 Oct 2024

Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database

in Pharmacoepidemiology

Wen-Long Xie
Meng-Lan Ge
Dan Chen
Guo-Qing Chen
Yuan-Xi Mei
Yong-Ji Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435923

9,201 views
15 citations

Systematic Review

Published on 10 Oct 2024

A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis

in Pharmacoepidemiology

Zhiyong Long
Liuting Zeng
Kailin Yang
Junpeng Chen
Yanfang Luo
Charles C. Dai
Qi He
Ying Deng
Anqi Ge
Xiaofei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440584

4,380 views
3 citations

Systematic Review

Published on 26 Sep 2024

Global research on sufentanil use in anesthesiology from 2003 to 2023: a bibliometric analysis

in Pharmacoepidemiology

Duoqin Huang
Zixin Luo
Xinyue Song
Kang Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412726

4,021 views
3 citations

Original Research

Published on 24 Sep 2024

Development and validation of a clinical prediction model for osteonecrosis of the jaw in patients receiving zoledronic acid using FAERS and canadian databases

in Pharmacoepidemiology

Zhen Wei
Chuan Hong
Chunhui Tu
Wukun Ge
Yaoyao Hu
Shuainan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456900

4,568 views
1 citation

Original Research

Published on 20 Sep 2024

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)

in Pharmacoepidemiology

Huafei Tang
Jing Xu
Xian Zhang
Chunliang Chen
Ge Song
Rui Ma
Jinjing Zhao
Qiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463560

3,901 views
2 citations

Original Research

Published on 19 Sep 2024

Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort

in Pharmacoepidemiology

Jonghyun Jeong
Kyu-Nam Heo
Suhyun Lee
Young-Mi Ah
Sangil Min
Ji Min Han
Ju-Yeun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399955

4,332 views
6 citations

Original Research

Published on 19 Sep 2024

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database

in Pharmacoepidemiology

Chang Ge
Liuyin Jin
Jing-Jing Tian
Na Yang
Jian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418609

4,288 views
4 citations

571 articles

articles

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)

Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials

Dispensing of zolpidem and benzodiazepines in Brazilian private pharmacies: a retrospective cohort study from 2014 to 2021

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)

Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study

Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data

Sex bias in prospective follow-up observational studies with drugs carried out in a southern region of Europe

Prevalence and influence factor of drug-related problems in inpatients with kidney disease: a prospective single central study

Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials

Nationwide usage of ethambutol and incidence and screening practices of optic neuropathy

Community pharmacists’ role towards preventing abuse or misuse and dependence of codeine-containing analgesic medications in Saudi Arabia: a multicenter cross-sectional study

Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database

A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis

Global research on sufentanil use in anesthesiology from 2003 to 2023: a bibliometric analysis

Development and validation of a clinical prediction model for osteonecrosis of the jaw in patients receiving zoledronic acid using FAERS and canadian databases

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)

Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database